Home > News > Prairie Cardiovascular Partners with Alivecor's Kardia Pro to Advance Breakthroughs in Cardiac Care

7/12/2017

Prairie Cardiovascular Partners with Alivecor's Kardia Pro to Advance Breakthroughs in Cardiac Care


Prairie Cardiovascular announced a two-phased partnership with AliveCor, manufacturer of Kardia Mobile. Kardia Mobile is an FDA-cleared personal EKG device. It’s smaller than a credit card and allows users to take a medical grade single-lead EKG in 30 seconds.

"Our first phase in the partnership was to provide all of our physicians and advance practice providers with a device," said Dr. Marc Shelton, past governor of the ACC and President of Prairie Cardiovascular. "We are often called upon to assist with medical emergencies outside of the walls of the hospital. This technology will be a great resource in these instances," said Shelton. "I was on an airplane recently and asked to assist with a passenger and having access to this type of device would have been helpful."

The second phase of the partnership, available to patients is August, will be deployment of AliveCor’s Kardia Pro, an industry-first artificial intelligence-enabled platform for doctors to monitor patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia that leads to a five times greater risk of stroke. Prairie's exclusive Kardia Pro software platform automatically receive the patient’s Kardia Mobile EKG readings, along with home blood pressure readings, activity levels, and weight changes taken with other devices compatible with Android and Apple smartphones. For the first time, artificial intelligence creates a personal heart profile for each user by training the app to recognize whether the primary user or a guest is taking the EKG recording. In the future, this heart profile may be used to notify doctors of changes to a patient's heart rhythm in real time, making it easier than ever for doctors to detect changes early and practice preventative medicine.

"This technology can help us with stroke prevention through earlier detection of atrial fibrillation," said Dr. Ziad Issa, medical director of cardiac electrophysiology at the Prairie Heart Institute at HSHS St. John's Hospital. "Prairie's use of Kardia Pro helps us to take a forward-looking approach to patient care."

According to Dr. Dave Albert, AliveCor Founder and Chief Medical Officer, "Heart disease and stroke are on the rise and the stakes for improving heart health are at an all-time high. Working with Prairie Cardiovascular, we look forward to supporting future developments in heart health.

###

About Prairie Cardiovascular
Prairie physicians at Prairie Cardiovascular are nationally recognized as leaders in cardiovascular care. More heart patients are cared for by Prairie than any other program in Illinois. Prairie currently has more than 70 board certified physicians and 45 clinic sites in Illinois. Prairie is a national leader in the innovation and development of new diagnostic and treatment procedures and continues to advance medicine with a very active research program. For more information, visit www.thedoctorsofprairie.com

About AliveCor Inc
AliveCor, Inc. is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile ECG solution on the market and is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. This simple-to-use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an ECG. Kardia Pro is the first AI-enabled platform for doctors to monitor patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia that leads to a five times greater risk of stroke. AliveCor was recognized by Fast Company as one of 2017's most innovative companies in health (#3 any headquartered in Mountain View, Calif. For more information, please visit alivecor.com.


Media Contact

Catie Sheehan
Executive Director of Communications, Marketing and Advocacy
Office: (217) 814-8377
Cell: (217) 220-1717
catie.sheehan@hshs.org

Erica Cusumano
Manager of Communications
Office: (217) 814-4307
Cell: (217) 303-6344
erica.cusumano@hshs.org


Connect